XNAS: SABS
SAB Biotherapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
SAB Biotherapeutics Inc is a clinical-stage biopharmaceutical company focused on developing multi-specific, high-potency, human immunoglobulin G (hIgG) to treat and prevent immune and autoimmune disorders. The company's lead product candidate, SAB-14...
Read More
3.56
0.08
(2.30%)
208.6K
XNAS Volume
XNAS 30 Jul, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for SAB Biotherapeutics Inc is on 07 Aug 2026 for the purpose of SAB Biotherapeutics Inc Second Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Bearish
SAB Biotherapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..